Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Chlorhexamed forte 0,2%, Lösung:GSK Consumer Healthcare Schweiz AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A01AB03 - ChlorhexidineATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
A01 - Stomatological Preparations
A01A - Stomatological Preparations

This group comprises agents for treatment of conditions of mouth and teeth. Preparations mainly used in gingivitis, stomatitis etc. should be classified in this group.
Preparations for the treatment of throat infections, (lozenges for common cold conditions) or treatment of symptoms both in mouth and throat are classified in R02 - Throat preparations.
Preparations containing local anesthetics, see N01B - Anesthetics, local, and R02AD - Anesthetics, local.

A01AB - Antiinfectives and Antiseptics for Local Oral Treatment

This group comprises all antiinfective and antiseptic agents for the treatment of stomatitis, gingivitis etc. Products used in common minor infections of mouth and throat are classified in R02, e.g. cetylpyridinium.
Other antibiotics for local use, see D - Dermatologicals.

The DDD for amphotericin in this group refers to lozenges.
The DDD for minocycline is based on the amount of active substance used in one periodontal pocket in local treatment of periodontitis.

A01AB03 - Chlorhexidine
2021 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home